ClinicalTrials.gov
public full text
Public Domain
Long Term Special Drug Use-results Surveillance for Mayzent in SPMS Patients
This study is a single cohort, central registration system, all-case, open-label, multicenter observational study in patients using Mayzent for the indication of secondary progressive multiple sclerosis.
Conceptio Open Archive
Analyze & explore related research in Conceptio
Connect this record directly into your research workflow or AI agent. Explore citations across open repositories, query full text, and export structured proof bundles.
This document is indexed with metadata only: full text is not available in the archive for this record. Open the official source ↗
Related documents
- A Single Ascending Dose Study of GZ402668 in Patients With Progressive Multiple Sclerosis#1174003
- Safety Study of an Immunomodulating Microparticle to Treat Progressive Multiple Sclerosis#426644
- Targeting progressive multiple sclerosis: Toward mechanism-informed precision medicine.#425139
- Incidence, and Survival Medical Expenditure of Patients With Multiple Sclerosis#866962
- Therapy Optimization in Multiple Sclerosis (MS)#873601
Record · ID 1096532
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Bring this data into your agent: Connect via MCP or API · 20 free credits to start · no card required
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive